Phlebitis Experiences of Intensive Care Nurses

NCT ID: NCT07051798

Last Updated: 2025-09-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-15

Study Completion Date

2025-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is important to reveal the phlebitis experiences of nurses. The data obtained from the phlebitis experiences of nurses are important in terms of preventing phlebitis and supporting patient safety practices. In the studies conducted to date, no study has been found in the literature that qualitatively examines the phlebitis experiences of intensive care nurses. This study is the first to be conducted in this respect, which constitutes the originality of the research. It is expected to guide clinician and academic nurses in phlebitis assessment and phlebitis care planning and to contribute to the literature.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Phlebitis NursİNG CARE

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

It is a qualitative type of study that will be conducted through face-to-face interviews.

It is a qualitative type of study that will be conducted through face-to-face interviews.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Voluntarily accepting to participate in the study
* Being the primary nurse of a patient who developed phlebitis,
* Having at least 1 year of work experience.

Exclusion Criteria

* Being assigned to the unit for a short period of time
* Being on leave or sick leave,
* Not accepting to participate in the study,
* Leaving the study during the data collection process.
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kutahya Health Sciences University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kutahya Health Sciences University

Kütahya, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

BURCU NAL, PhD

Role: primary

05077769735

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KHSU20250607

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.